%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Nathan O. Siemers, James L. Holloway, Han Chang, Scott D. Chasalow, Petra B. Ross-MacDonald, Charles F. Voliva, Joseph D. Szustakowski
Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref004)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref005)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref008)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref009)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref010)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref011)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref012)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref013)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref014)>>
endobj
27 0 obj
<>/Border[0 0 0]/A 33 0 R>>
endobj
33 0 obj
<>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref015)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref016)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref008)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref017)>>
endobj
32 0 obj
<>/Border[0 0 0]/A 34 0 R>>
endobj
34 0 obj
<>
endobj
14 0 obj
[35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R]
endobj
35 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 680.2299 m
199.9998 680.2299 l
199.9998 680.73 l
575.9997 680.73 l
f*
0.83 0.64 0.02 0 k
381.6567 562.9039 m
386.4189 562.9039 l
h
f*
230.9669 523.8992 m
235.7291 523.8992 l
h
f*
237.9969 523.8992 m
242.7024 523.8992 l
h
f*
438.6331 497.9339 m
443.3386 497.9339 l
h
f*
515.0551 484.8945 m
519.8173 484.8945 l
h
f*
524.9764 484.8945 m
529.7386 484.8945 l
h
f*
368.7307 471.9118 m
373.4929 471.9118 l
h
f*
375.7606 471.9118 m
385.285 471.9118 l
h
f*
278.6457 432.9071 m
288.1701 432.9071 l
h
f*
290.3811 432.9071 m
299.9055 432.9071 l
h
f*
232.2709 354.8976 m
241.7386 354.8976 l
h
f*
244.0063 354.8976 m
253.5307 354.8976 l
h
f*
400.252 302.9102 m
519.137 302.9102 l
h
f*
528.1512 302.9102 m
537.6189 302.9102 l
h
f*
361.9276 276.9449 m
371.3953 276.9449 l
h
f*
296.2205 250.9228 m
300.9827 250.9228 l
h
f*
231.3638 107.9433 m
240.8882 107.9433 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(immune)Tj
3.7417 0 Td
(therapies.)Tj
4.5593 0 Td
(Others,)Tj
3.4731 0 Td
(like)Tj
1.6948 0 Td
(mutations)Tj
4.5176 0 Td
(in)Tj
0.9787 0 Td
(cell)Tj
1.6948 0 Td
(death)Tj
2.6974 0 Td
(pathways,)Tj
4.6786 0 Td
(may)Tj
2.0946 0 Td
(help)Tj
2.0768 0 Td
(guide)Tj
2.6317 0 Td
(combina-)Tj
-34.8391 -1.474 Td
(tion)Tj
1.8081 0 Td
(therapeutic)Tj
5.1084 0 Td
(approaches.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 619.9937 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 602.9858 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Checkpoint)Tj
4.8925 0 Td
(blocking)Tj
3.6794 0 Td
(cancer)Tj
2.8459 0 Td
(therapeutics,)Tj
5.3178 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(ipilimumab,)Tj
5.1194 0 Td
(nivolumab,)Tj
4.7565 0 Td
(pembrolizumab)Tj
-29.6842 -1.2982 Td
(and)Tj
1.7291 0 Td
(atezolizumab,)Tj
5.7373 0 Td
(act)Tj
1.3719 0 Td
(by)Tj
1.1849 0 Td
(targeting)Tj
3.7927 0 Td
(immune)Tj
3.6227 0 Td
(cell)Tj
1.559 0 Td
(signaling)Tj
3.8268 0 Td
(molecules)Tj
4.1952 0 Td
(rather)Tj
2.6476 0 Td
(than)Tj
2.0296 0 Td
(targeting)Tj
3.7927 0 Td
(the)Tj
-35.4895 -1.2983 Td
(tumor)Tj
2.7439 0 Td
(directly.)Tj
3.4582 0 Td
(The)Tj
1.7802 0 Td
(molecular)Tj
4.2179 0 Td
(targets)Tj
2.8743 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2507 0 Td
(agents,)Tj
2.9764 0 Td
(CTLA-4,)Tj
3.77 0 Td
(PD-1,)Tj
2.5682 0 Td
(and)Tj
1.7291 0 Td
(PD-L1,)Tj
3.1068 0 Td
(are)Tj
1.4456 0 Td
(compo-)Tj
-33.9361 -1.3039 Td
(nents)Tj
2.398 0 Td
(of)Tj
1.0148 0 Td
(pathways)Tj
3.9345 0 Td
(that)Tj
1.7745 0 Td
(inhibit)Tj
2.9026 0 Td
(T)Tj
0.8334 0 Td
(cell)Tj
1.5591 0 Td
(function[)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
5.0116 0 Td
(Clinical)Tj
3.3165 0 Td
(experience)Tj
4.5071 0 Td
(with)Tj
1.9955 0 Td
(checkpoint)Tj
4.6545 0 Td
(blockade)Tj
-33.9021 -1.2983 Td
(monotherapy)Tj
5.6295 0 Td
(and)Tj
1.7291 0 Td
(combinations)Tj
5.709 0 Td
(has)Tj
1.542 0 Td
(demonstrated)Tj
5.76 0 Td
(dramatic)Tj
3.7984 0 Td
(tumor)Tj
2.7439 0 Td
(shrinkage)Tj
4.1102 0 Td
(and)Tj
1.7348 0 Td
(long-term)Tj
-32.7569 -1.2982 Td
(durable,)Tj
3.4809 0 Td
(often)Tj
2.2847 0 Td
(drug-free,)Tj
4.1952 0 Td
(survival)Tj
3.3392 0 Td
(in)Tj
1.0318 0 Td
(some)Tj
2.3301 0 Td
(patients;)Tj
3.5943 0 Td
(however,)Tj
3.8381 0 Td
(many)Tj
2.4775 0 Td
(patients)Tj
3.3675 0 Td
(do)Tj
1.2529 0 Td
(not)Tj
1.576 0 Td
(appear)Tj
2.9197 0 Td
(to)Tj
-35.6879 -1.3039 Td
(benefit[)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
5.0569 0 Td
(A)Tj
0.9014 0 Td
(number)Tj
3.4186 0 Td
(of)Tj
1.0148 0 Td
(different)Tj
3.6567 0 Td
(parameters)Tj
4.6771 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.1203 0 Td
(explored)Tj
3.7021 0 Td
(to)Tj
1.0261 0 Td
(predict)Tj
3.0501 0 Td
(and)Tj
1.7291 0 Td
(explain)Tj
3.1237 0 Td
(the)Tj
-35.5348 -1.2983 Td
(heterogeneity)Tj
5.6522 0 Td
(of)Tj
1.0148 0 Td
(patient)Tj
3.0047 0 Td
(benefit,)Tj
3.2031 0 Td
(within)Tj
2.812 0 Td
(and)Tj
1.7291 0 Td
(across)Tj
2.6816 0 Td
(different)Tj
3.651 0 Td
(cancer)Tj
2.8459 0 Td
(types.)Tj
2.5002 0 Td
(These)Tj
2.5681 0 Td
(include)Tj
3.1862 0 Td
(differ-)Tj
-34.8489 -1.2983 Td
(ences)Tj
2.398 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(activation)Tj
4.1499 0 Td
(state)Tj
2.0352 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(tumor-immune)Tj
6.497 0 Td
(infiltrate[)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(],)Tj
5.0456 0 Td
(differences)Tj
4.5638 0 Td
(in)Tj
1.0374 0 Td
(antigenicity)Tj
4.9153 0 Td
(of)Tj
-35.6369 -1.3039 Td
(the)Tj
1.4683 0 Td
(cancer)Tj
2.846 0 Td
(cells)Tj
1.9162 0 Td
(due)Tj
1.7007 0 Td
(to)Tj
1.0262 0 Td
(differential)Tj
4.6034 0 Td
(expression)Tj
4.4674 0 Td
(and)Tj
1.7291 0 Td
(presentation)Tj
5.2157 0 Td
(of)Tj
1.0148 0 Td
(neo-antigens[)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(],)Tj
7.7726 0 Td
(and)Tj
1.7291 0 Td
(dif-)Tj
-35.4895 -1.2983 Td
(ferences)Tj
3.4809 0 Td
(in)Tj
1.0374 0 Td
(composition)Tj
5.2441 0 Td
(of)Tj
1.0148 0 Td
(intestinal)Tj
3.9118 0 Td
(flora[)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
4.6204 0 Td
(One)Tj
1.9389 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(most)Tj
2.2054 0 Td
(extensively)Tj
4.5864 0 Td
(studied)Tj
3.1521 0 Td
(potential)Tj
-33.681 -1.2982 Td
(biomarkers)Tj
4.7791 0 Td
(for)Tj
1.3833 0 Td
(checkpoint)Tj
4.6545 0 Td
(blocking)Tj
3.6793 0 Td
(agents)Tj
2.7496 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4684 0 Td
(cell)Tj
1.559 0 Td
(surface)Tj
3.0501 0 Td
(expression)Tj
4.4673 0 Td
(of)Tj
1.0148 0 Td
(PD-L1,)Tj
3.1011 0 Td
(which)Tj
2.6532 0 Td
(is)Tj
-35.4101 -1.2983 Td
(induced)Tj
3.4639 0 Td
(by)Tj
1.1848 0 Td
(interferon)Tj
4.2633 0 Td
(gamma)Tj
3.1918 0 Td
(from)Tj
2.2054 0 Td
(infiltrating)Tj
4.524 0 Td
(lymphocytes)Tj
5.2497 0 Td
(and)Tj
1.7348 0 Td
(may)Tj
1.9276 0 Td
(be)Tj
1.1508 0 Td
(a)Tj
0.652 0 Td
(surrogate)Tj
3.9798 0 Td
(for)Tj
-33.5279 -1.3039 Td
(inflammatory)Tj
5.7089 0 Td
(state[)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
-4.5127 -1.2983 Td
(In)Tj
1.1111 0 Td
(addition)Tj
3.6 0 Td
(to)Tj
1.0205 0 Td
(passenger)Tj
4.1272 0 Td
(mutations)Tj
4.2803 0 Td
(which)Tj
2.6532 0 Td
(can)Tj
1.6271 0 Td
(lead)Tj
1.8482 0 Td
(to)Tj
1.0261 0 Td
(expression)Tj
4.4674 0 Td
(of)Tj
1.0148 0 Td
(neo-antigens,)Tj
5.6182 0 Td
(the)Tj
-33.5903 -1.2982 Td
(genetic)Tj
3.067 0 Td
(history)Tj
3.0104 0 Td
(of)Tj
1.0148 0 Td
(tumorigenesis,)Tj
6.0831 0 Td
(manifest)Tj
3.6623 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(pattern)Tj
3.1124 0 Td
(of)Tj
1.0148 0 Td
(driver)Tj
2.6362 0 Td
(mutations)Tj
4.2803 0 Td
(and)Tj
1.7291 0 Td
(other)Tj
2.3471 0 Td
(neces-)Tj
-34.4634 -1.3039 Td
(sary)Tj
1.8425 0 Td
(changes)Tj
3.4015 0 Td
(acquired)Tj
3.702 0 Td
(during)Tj
2.9254 0 Td
(development,)Tj
5.6352 0 Td
(may)Tj
1.9276 0 Td
(affect)Tj
2.3754 0 Td
(the)Tj
1.474 0 Td
(inflammatory)Tj
5.7033 0 Td
(state.)Tj
2.262 0 Td
(Tumor)Tj
3.0557 0 Td
(driver)Tj
-34.3046 -1.2983 Td
(pathways,)Tj
4.1555 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(WNT/Beta-catenin)Tj
7.8916 0 Td
(and)Tj
1.7347 0 Td
(FAK,)Tj
2.3301 0 Td
(have)Tj
2.058 0 Td
(been)Tj
2.1259 0 Td
(recently)Tj
3.4072 0 Td
(linked)Tj
2.7326 0 Td
(with)Tj
1.9956 0 Td
(immune)Tj
3.6227 0 Td
(state)Tj
-35.1267 -1.2983 Td
(in)Tj
1.0318 0 Td
(human)Tj
3.0784 0 Td
(tumors)Tj
3.1067 0 Td
(and)Tj
1.7291 0 Td
(identified)Tj
4.0592 0 Td
(as)Tj
1.0148 0 Td
(specific)Tj
3.1918 0 Td
(modulators)Tj
4.8189 0 Td
(of)Tj
1.0148 0 Td
(immune)Tj
3.6283 0 Td
(function)Tj
3.6283 0 Td
(in)Tj
1.0375 0 Td
(animal)Tj
2.965 0 Td
(tumor)Tj
-34.3046 -1.3039 Td
(models[)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
6.1398 0 Td
(However,)Tj
4.0761 0 Td
(these)Tj
2.2507 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.058 0 Td
(focused)Tj
3.2825 0 Td
(on)Tj
1.2756 0 Td
(specific)Tj
3.1861 0 Td
(cancer)Tj
2.846 0 Td
(driver)Tj
2.6362 0 Td
(pathway)Tj
3.5716 0 Td
(hypoth-)Tj
-34.3103 -1.2983 Td
(eses,)Tj
2.0125 0 Td
(and)Tj
1.7292 0 Td
(have)Tj
2.0636 0 Td
(yet)Tj
1.3946 0 Td
(to)Tj
1.0261 0 Td
(report)Tj
2.7099 0 Td
(their)Tj
2.1033 0 Td
(results)Tj
2.812 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(context)Tj
3.1861 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(systematic)Tj
4.3596 0 Td
(genetic)Tj
3.0728 0 Td
(analysis.)Tj
3.5489 0 Td
(Rooney)Tj
/F10 1 Tf
-34.1912 -1.2982 Td
[()8()]TJ
/F5 1 Tf
(.)Tj
/F10 1 Tf
1.1338 0 Td
[()11()]TJ
/F5 1 Tf
(.)Tj
1.1679 0 Td
(have)Tj
2.0579 0 Td
(reported)Tj
3.6623 0 Td
(a)Tj
0.652 0 Td
(landmark)Tj
4.0989 0 Td
(study)Tj
2.3924 0 Td
(describing)Tj
4.3823 0 Td
(many)Tj
2.4775 0 Td
(tumor)Tj
2.7439 0 Td
(parameters,)Tj
4.8983 0 Td
(including)Tj
4.0421 0 Td
(genetic,)Tj
-33.7093 -1.2983 Td
(that)Tj
1.7744 0 Td
(influence)Tj
3.9175 0 Td
(the)Tj
1.474 0 Td
(strength)Tj
3.5093 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
('cytotoxic)Tj
4.0762 0 Td
(T)Tj
0.8334 0 Td
(cell)Tj
1.559 0 Td
(signature')Tj
4.1329 0 Td
(in)Tj
1.0375 0 Td
(tumors)Tj
3.1011 0 Td
(across)Tj
2.6758 0 Td
(The)Tj
1.7859 0 Td
(Cancer)Tj
-31.5494 -1.3039 Td
(Genome)Tj
3.6566 0 Td
(Atlas)Tj
2.245 0 Td
(\(TCGA,)Tj
3.4583 0 Td
(TCGA)Tj
2.8913 0 Td
(Research)Tj
3.8098 0 Td
(Network:)Tj
0.83 0.64 0.02 0 k
3.9628 0 Td
(http://cancergenome.nih.gov/)Tj
0 g
(\))Tj
12.4496 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
2.075 0 Td
(Porta-)Tj
-34.5484 -1.2983 Td
(Pardo)Tj
2.6191 0 Td
(and)Tj
1.7292 0 Td
(Godzik)Tj
3.1464 0 Td
(have)Tj
2.0579 0 Td
(also)Tj
1.7689 0 Td
(studied)Tj
3.1521 0 Td
(the)Tj
1.474 0 Td
(association)Tj
4.6261 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.8459 0 Td
(mutations)Tj
4.2803 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6576 0 Td
(general)Tj
3.1295 0 Td
(esti-)Tj
-34.4974 -1.2982 Td
(mate)Tj
2.194 0 Td
(of)Tj
1.0147 0 Td
(immune)Tj
3.6284 0 Td
(infiltrate)Tj
3.6623 0 Td
(across)Tj
2.6759 0 Td
(TCGA[)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
4.7508 0 Td
(Mutations)Tj
4.354 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4684 0 Td
(interferon)Tj
4.2689 0 Td
(gamma)Tj
-34.2706 -1.304 Td
(signaling)Tj
3.821 0 Td
(and)Tj
1.7292 0 Td
(antigen)Tj
3.2087 0 Td
(presentation)Tj
5.2158 0 Td
(pathways)Tj
3.9344 0 Td
(have)Tj
2.058 0 Td
(recently)Tj
3.4072 0 Td
(been)Tj
2.126 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(acquired)Tj
3.702 0 Td
(resis-)Tj
-35.4555 -1.2982 Td
(tance)Tj
2.347 0 Td
(to)Tj
1.0262 0 Td
(PD-1)Tj
2.3414 0 Td
(blockade[)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
5.1647 0 Td
(We)Tj
1.61 0 Td
(sought)Tj
2.9083 0 Td
(to)Tj
1.0205 0 Td
(discern)Tj
3.1465 0 Td
(whether)Tj
3.4752 0 Td
(tumor)Tj
2.7439 0 Td
(genetic)Tj
3.0728 0 Td
(profiles)Tj
3.1974 0 Td
(could)Tj
2.4548 0 Td
(gener-)Tj
-34.5087 -1.2983 Td
(ally)Tj
1.5987 0 Td
(be)Tj
1.1508 0 Td
(correlated)Tj
4.2463 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.474 0 Td
(composition)Tj
5.2441 0 Td
(of)Tj
1.0148 0 Td
(specific)Tj
3.1861 0 Td
(subtypes)Tj
3.6737 0 Td
(of)Tj
1.0148 0 Td
(tumor)Tj
2.7439 0 Td
(immune)Tj
3.6226 0 Td
(infiltrate.)Tj
-29.7692 -1.3039 Td
(We)Tj
1.61 0 Td
(have)Tj
2.0636 0 Td
(performed)Tj
4.4674 0 Td
(a)Tj
0.652 0 Td
(systematic)Tj
4.3653 0 Td
(interrogation)Tj
5.5275 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(complex)Tj
3.6226 0 Td
(associations)Tj
4.989 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.8403 0 Td
(muta-)Tj
-34.8319 -1.2983 Td
(tion)Tj
1.8425 0 Td
(and)Tj
1.7291 0 Td
(copy)Tj
2.1203 0 Td
(number)Tj
3.4185 0 Td
(alterations)Tj
4.4107 0 Td
(\(CNA\))Tj
2.9821 0 Td
(with)Tj
1.9955 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(immune)Tj
3.6284 0 Td
(infiltrate)Tj
3.6623 0 Td
(across)Tj
2.6759 0 Td
(solid)Tj
2.1316 0 Td
(TCGA)Tj
-33.9871 -1.2982 Td
(tumors.)Tj
3.3278 0 Td
(Immune)Tj
3.702 0 Td
(cell)Tj
1.5591 0 Td
(levels)Tj
2.3754 0 Td
(were)Tj
2.1203 0 Td
(estimated)Tj
4.0762 0 Td
(using)Tj
2.3867 0 Td
(novel)Tj
2.3981 0 Td
(transcriptional)Tj
6.1172 0 Td
(marker)Tj
3.1351 0 Td
(sets)Tj
1.6611 0 Td
(for)Tj
1.3889 0 Td
(major)Tj
-34.2479 -1.3039 Td
(immune)Tj
3.6226 0 Td
(cell)Tj
1.559 0 Td
(types,)Tj
2.5059 0 Td
(which)Tj
2.6475 0 Td
(were)Tj
2.1203 0 Td
(trained)Tj
3.0954 0 Td
(to)Tj
1.0205 0 Td
(resist)Tj
2.3017 0 Td
(interference)Tj
5.0343 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4684 0 Td
(cellular)Tj
3.1407 0 Td
(and)Tj
1.7292 0 Td
(transcrip-)Tj
-32.4508 -1.2983 Td
(tional)Tj
2.5171 0 Td
(complexity)Tj
4.6431 0 Td
(of)Tj
1.0148 0 Td
(tumors.)Tj
3.3335 0 Td
(We)Tj
1.6101 0 Td
(also)Tj
1.7688 0 Td
(attempted)Tj
4.2576 0 Td
(to)Tj
1.0262 0 Td
(address)Tj
3.2258 0 Td
(several)Tj
2.9366 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(biases)Tj
2.5738 0 Td
(that)Tj
1.7745 0 Td
(introduce)Tj
-33.1651 -1.2983 Td
(complexity)Tj
4.6431 0 Td
(in)Tj
1.0318 0 Td
(multi-modal)Tj
5.2667 0 Td
(TCGA)Tj
2.8913 0 Td
(data)Tj
1.9162 0 Td
(analysis)Tj
3.3279 0 Td
(in)Tj
1.0318 0 Td
(our)Tj
1.6271 0 Td
(analytical)Tj
4.0081 0 Td
(models.)Tj
3.3279 0 Td
(We)Tj
1.6101 0 Td
(have)Tj
2.0636 0 Td
(identified)Tj
-32.7456 -1.2982 Td
(both)Tj
2.0579 0 Td
(previously)Tj
4.354 0 Td
(reported)Tj
3.6566 0 Td
(and)Tj
1.7292 0 Td
(novel)Tj
2.4037 0 Td
(mechanisms)Tj
5.2044 0 Td
(by)Tj
1.1792 0 Td
(which)Tj
2.6532 0 Td
(tumor)Tj
2.7439 0 Td
(genetics)Tj
3.4299 0 Td
(may)Tj
1.9276 0 Td
(influence)Tj
-31.3396 -1.304 Td
(immune)Tj
3.6226 0 Td
(state.)Tj
2.262 0 Td
(Additionally,)Tj
5.4539 0 Td
(we)Tj
1.3266 0 Td
(observed)Tj
3.7984 0 Td
(changes)Tj
3.4015 0 Td
(that)Tj
1.7802 0 Td
(suggest)Tj
3.1237 0 Td
(some)Tj
2.3301 0 Td
(tumors)Tj
3.1011 0 Td
(may)Tj
1.9332 0 Td
(genetically)Tj
-32.1333 -1.2982 Td
(adapt)Tj
2.4321 0 Td
(to)Tj
1.0204 0 Td
(ongoing)Tj
3.532 0 Td
(immune)Tj
3.6283 0 Td
(responses)Tj
4.0932 0 Td
(in)Tj
1.0318 0 Td
(ways)Tj
2.1543 0 Td
(that)Tj
1.7802 0 Td
(may)Tj
1.9275 0 Td
(broaden)Tj
3.5376 0 Td
(our)Tj
1.6271 0 Td
(definitions)Tj
4.5241 0 Td
(of)Tj
1.0148 0 Td
(immuno-)Tj
-32.3034 -1.2983 Td
(editing[)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
4.8755 0 Td
(Other)Tj
2.5852 0 Td
(associations)Tj
4.9889 0 Td
(of)Tj
1.0148 0 Td
(genetic)Tj
3.0671 0 Td
(changes)Tj
3.4072 0 Td
(with)Tj
1.9956 0 Td
(immune)Tj
3.6283 0 Td
(dynamics)Tj
4.0535 0 Td
(may)Tj
1.9276 0 Td
(reflect)Tj
2.6986 0 Td
(the)Tj
1.4683 0 Td
(evo-)Tj
-35.7106 -1.3039 Td
(lutionary)Tj
3.8721 0 Td
(history)Tj
3.0103 0 Td
(of)Tj
1.0148 0 Td
(tumor)Tj
2.7439 0 Td
(subtypes)Tj
3.6681 0 Td
(in)Tj
1.0374 0 Td
(indirect)Tj
3.3449 0 Td
(ways,)Tj
2.3811 0 Td
(serving)Tj
3.1124 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(proxy)Tj
2.5341 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(tumors')Tj
3.3222 0 Td
(latent)Tj
-34.5654 -1.2983 Td
(characteristics.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 371.9622 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Identifying)Tj
4.6913 0 Td
(genetic)Tj
3.3804 0 Td
(correlates)Tj
4.5354 0 Td
(of)Tj
1.0418 0 Td
(immune)Tj
3.7205 0 Td
(infiltrate)Tj
3.4228 0 Td
(s)Tj
0.7158 0 Td
(in)Tj
0.978 0 Td
(tumors)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01797)Tj
4.089 0 Td
(26)Tj
0 g
2.0906 0 Td
(July)Tj
1.9701 0 Td
(27,)Tj
1.5874 0 Td
(2017)Tj
35.3483 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(24)Tj
/F8 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(TCGA)Tj
2.3315 0 Td
(data)Tj
1.7929 0 Td
(used)Tj
2.0055 0 Td
(in)Tj
0.8929 0 Td
(this)Tj
1.5591 0 Td
(work)Tj
2.0622 0 Td
(may)Tj
1.8142 0 Td
(be)Tj
1.1197 0 Td
(made)Tj
-13.578 -1.3748 Td
(available)Tj
3.3803 0 Td
(upon)Tj
2.1118 0 Td
(request.)Tj
3.2174 0 Td
(Requests)Tj
3.6992 0 Td
(may)Tj
1.8142 0 Td
(be)Tj
1.1126 0 Td
(sent)Tj
1.7929 0 Td
(to)Tj
-17.1284 -1.3749 Td
(the)Tj
1.3677 0 Td
(corresponding)Tj
5.6055 0 Td
(author.)Tj
/F7 1 Tf
-6.9732 -2.126 Td
(Funding:)Tj
/F8 1 Tf
3.5716 0 Td
(All)Tj
1.1339 0 Td
(of)Tj
0.9425 0 Td
(the)Tj
1.3748 0 Td
(authors)Tj
3.0473 0 Td
(of)Tj
0.9425 0 Td
(this)Tj
1.5662 0 Td
(manuscript)Tj
4.415 0 Td
(are)Tj
-16.9938 -1.3748 Td
(salaried)Tj
3.0756 0 Td
(employe)Tj
3.1535 0 Td
(es)Tj
1.063 0 Td
(of)Tj
0.9496 0 Td
(Bristol-Myer)Tj
4.578 0 Td
(s)Tj
0.6449 0 Td
(Squibb)Tj
-13.4646 -1.3748 Td
(Company,)Tj
3.9897 0 Td
(a)Tj
0.6378 0 Td
(Biopharma)Tj
4.2662 0 Td
(compa)Tj
2.537 0 Td
(ny)Tj
1.1197 0 Td
(in)Tj
0.8859 0 Td
(the)Tj
1.3677 0 Td
(business)Tj
-14.804 -1.3748 Td
(of)Tj
0.9496 0 Td
(developing)Tj
4.2378 0 Td
(and)Tj
1.5874 0 Td
(marketing)Tj
3.9402 0 Td
(therapeutic)Tj
4.337 0 Td
(drugs.)Tj
-15.052 -1.3748 Td
(The)Tj
1.5874 0 Td
(Company)Tj
3.763 0 Td
(did)Tj
1.3606 0 Td
(not)Tj
1.4244 0 Td
(influenc)Tj
2.8985 0 Td
(e)Tj
0.6449 0 Td
(study)Tj
2.2677 0 Td
(design,)Tj
2.8985 0 Td
(data)Tj
-16.845 -1.3748 Td
(collection,)Tj
3.9614 0 Td
(nor)Tj
1.474 0 Td
(analysis,)Tj
3.4158 0 Td
(but)Tj
1.4173 0 Td
(supported)Tj
3.9969 0 Td
(our)Tj
1.474 0 Td
(research)Tj
-15.7394 -1.3748 Td
(in)Tj
0.8858 0 Td
(general,)Tj
3.1536 0 Td
(and)Tj
1.5945 0 Td
(approved)Tj
3.685 0 Td
(the)Tj
1.3677 0 Td
(release)Tj
2.8276 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
-14.4638 -1.3749 Td
(publication.)Tj
4.4858 0 Td
(The)Tj
1.5945 0 Td
(specific)Tj
3.0189 0 Td
(roles)Tj
2.0339 0 Td
(of)Tj
0.9496 0 Td
(these)Tj
2.2111 0 Td
(authors)Tj
3.0472 0 Td
(are)Tj
-17.341 -1.3748 Td
(articulated)Tj
4.0535 0 Td
(in)Tj
0.8929 0 Td
(the)Tj
1.3678 0 Td
('author)Tj
2.8134 0 Td
(contributions')Tj
5.3008 0 Td
(section.)Tj
/F7 1 Tf
-14.4284 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F8 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(are)Tj
1.3748 0 Td
(employe)Tj
3.1536 0 Td
(d)Tj
0.6945 0 Td
(at)Tj
-18.0426 -1.3748 Td
(Bristol-My)Tj
3.848 0 Td
(ers)Tj
1.3748 0 Td
(Squibb,)Tj
3.0544 0 Td
(which)Tj
2.4236 0 Td
(discove)Tj
2.8205 0 Td
(red)Tj
1.4244 0 Td
(and)Tj
-14.9457 -1.3748 Td
(commercial)Tj
4.3583 0 Td
(ized)Tj
1.6724 0 Td
(ipilimu)Tj
2.4662 0 Td
(mab)Tj
1.8708 0 Td
(and)Tj
1.5875 0 Td
(nivolumab)Tj
-11.9552 -1.3748 Td
(therapies)Tj
3.6071 0 Td
(for)Tj
1.2543 0 Td
(cancer.)Tj
2.9126 0 Td
(There)Tj
2.3174 0 Td
(are)Tj
1.3677 0 Td
(no)Tj
1.1693 0 Td
(patents,)Tj
3.1677 0 Td
(clinical)Tj
-15.7961 -1.3748 Td
(research)Tj
3.4157 0 Td
(programs)Tj
3.6284 0 Td
(,)Tj
0.4465 0 Td
(nor)Tj
1.474 0 Td
(marketed)Tj
3.6992 0 Td
(products)Tj
3.515 0 Td
(to)Tj
-16.1788 -1.3748 Td
(declare)Tj
2.8771 0 Td
(that)Tj
1.63 0 Td
(are)Tj
1.3677 0 Td
(directly)Tj
2.9055 0 Td
(related)Tj
2.7142 0 Td
(to)Tj
0.9496 0 Td
(this)Tj
1.5662 0 Td
(manuscr)Tj
3.267 0 Td
(ipt.)Tj
-17.2773 -1.3748 Td
(Bristol-My)Tj
3.848 0 Td
(ers)Tj
1.3748 0 Td
(Squibb)Tj
2.8276 0 Td
(has)Tj
1.5378 0 Td
(major)Tj
2.374 0 Td
(efforts)Tj
2.6079 0 Td
(in)Tj
0.8859 0 Td
(the)Tj
1.3677 0 Td
(area)Tj
-16.8237 -1.3749 Td
(of)Tj
0.9496 0 Td
(immuno-o)Tj
3.8976 0 Td
(ncology)Tj
3.1536 0 Td
(in)Tj
0.8858 0 Td
(general.)Tj
3.1536 0 Td
(Our)Tj
1.5874 0 Td
(affiliation)Tj
3.5504 0 Td
(with)Tj
-17.178 -1.3748 Td
(Bristol-My)Tj
3.848 0 Td
(ers)Tj
1.3748 0 Td
(Squibb)Tj
2.8276 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4244 0 Td
(alter)Tj
1.8142 0 Td
(our)Tj
1.4741 0 Td
(adherence)Tj
-14.7757 -1.3748 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8709 0 Td
(policies)Tj
3.0047 0 Td
(on)Tj
1.1693 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
ET
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
BT
0 52.3421 Td
(materials.)Tj
ET
Q
endstream
endobj
52 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 53 0 R/Contents 54 0 R/TrimBox[0 0 612 792]>>
endobj
53 0 obj
[55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R]
endobj
55 0 obj
<>/Border[0 0 0]/A 72 0 R>>
endobj
72 0 obj
<>
endobj
56 0 obj
<>/Border[0 0 0]/A 73 0 R>>
endobj
73 0 obj
<>
endobj
57 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref018)>>
endobj
58 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref019)>>
endobj
59 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref020)>>
endobj
60 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.g001)>>
endobj
61 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref021)>>
endobj
62 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref015)>>
endobj
63 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref022)>>
endobj
64 0 obj
<>/Border[0 0 0]/Dest(Rsec005)>>
endobj
65 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.ref023)>>
endobj
66 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.t001)>>
endobj
67 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.g001)>>
endobj
68 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.g001)>>
endobj
69 0 obj
<>/Border[0 0 0]/Dest(Rpone.0179726.g001)>>
endobj
70 0 obj
<>/Border[0 0 0]/Dest(Rsec005)>>
endobj
71 0 obj
<>/Border[0 0 0]/A 74 0 R>>
endobj
74 0 obj
<>
endobj
54 0 obj
[75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R]
endobj
75 0 obj
<>stream
q
0.83 0.64 0.02 0 k
508.4787 622.9984 m
569.4803 622.9984 l
h
f*
200.0126 610.0157 m
213.4488 610.0157 l
h
f*
220.252 610.0157 m
229.7764 610.0157 l
h
f*
231.9874 610.0157 m
241.5118 610.0157 l
h
f*
238.3937 583.9937 m
247.8614 583.9937 l
h
f*
254.6646 583.9937 m
281.0835 583.9937 l
h
f*
533.1969 532.0063 m
542.7213 532.0063 l
h
f*
220.422 453.9969 m
229.8898 453.9969 l
h
f*
232.1575 453.9969 m
241.6819 453.9969 l
h
f*
323.7165 324 m
359.0929 324 l
h
f*
427.578 311.0173 m
437.1024 311.0173 l
h
f*
446.0598 311.0173 m
475.2567 311.0173 l
h
f*
211.9748 233.0079 m
237.3732 233.0079 l
h
f*
390.4441 154.9984 m
416.6362 154.9984 l
h
f*
349.2283 115.9937 m
376.1008 115.9937 l
h
f*
392.9953 90.0283 m
428.3717 90.0283 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Results)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(In)Tj
1.1055 0 Td
(our)Tj
1.627 0 Td
(experience,)Tj
4.7339 0 Td
(many)Tj
2.4774 0 Td
(transcriptional)Tj
6.1115 0 Td
(marker)Tj
3.1351 0 Td
(sets)Tj
1.6667 0 Td
(for)Tj
1.3833 0 Td
(immune)Tj
3.6284 0 Td
(cells)Tj
1.9218 0 Td
(derived)Tj
3.2145 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4684 0 Td
(litera-)Tj
-34.6788 -1.3039 Td
(ture)Tj
1.8425 0 Td
(or)Tj
1.0941 0 Td
(trained)Tj
3.0898 0 Td
(from)Tj
2.2053 0 Td
(data)Tj
1.9162 0 Td
(on)Tj
1.2756 0 Td
(cell-sorted)Tj
4.3993 0 Td
(peripheral)Tj
4.32 0 Td
(blood)Tj
2.5115 0 Td
(immune)Tj
3.6283 0 Td
(cells)Tj
1.9219 0 Td
(perform)Tj
3.5149 0 Td
(poorly)Tj
2.8233 0 Td
(when)Tj
-34.5427 -1.2982 Td
(applied)Tj
3.1521 0 Td
(to)Tj
1.0261 0 Td
(data)Tj
1.9105 0 Td
(derived)Tj
3.2202 0 Td
(from)Tj
2.2053 0 Td
(tumor)Tj
2.7439 0 Td
(samples.)Tj
3.6057 0 Td
(Sometimes,)Tj
4.8415 0 Td
(even)Tj
2.0693 0 Td
(markers)Tj
3.4979 0 Td
(viewed)Tj
2.9991 0 Td
(as)Tj
1.0148 0 Td
(canonical)Tj
4.0535 0 Td
(for)Tj
-36.3399 -1.2983 Td
(immune)Tj
3.6226 0 Td
(cell)Tj
1.559 0 Td
(types)Tj
2.2791 0 Td
(are)Tj
1.4457 0 Td
(not)Tj
1.576 0 Td
(always)Tj
2.8346 0 Td
(specific)Tj
3.1918 0 Td
(in)Tj
1.0318 0 Td
(RNA-seq)Tj
3.9061 0 Td
(data.)Tj
2.1374 0 Td
(For)Tj
1.627 0 Td
(example,)Tj
3.7758 0 Td
(data)Tj
1.9162 0 Td
(from)Tj
2.2053 0 Td
(sorted)Tj
-33.1084 -1.3039 Td
(human)Tj
3.0784 0 Td
(immune)Tj
3.6226 0 Td
(populations)Tj
4.9549 0 Td
(within)Tj
2.812 0 Td
(the)Tj
1.4683 0 Td
(Immunological)Tj
6.3723 0 Td
(Genome)Tj
3.6566 0 Td
(Project)Tj
3.0614 0 Td
(suggests)Tj
3.481 0 Td
(that)Tj
1.7801 0 Td
(CD4)Tj
-34.2876 -1.2983 Td
(transcription)Tj
5.4311 0 Td
(is)Tj
0.8504 0 Td
(higher)Tj
2.8006 0 Td
(on)Tj
1.2756 0 Td
(monocytes)Tj
4.5637 0 Td
(than)Tj
2.0296 0 Td
(on)Tj
1.2756 0 Td
(CD4+)Tj
2.6759 0 Td
(T)Tj
0.8277 0 Td
(cells)Tj
1.9219 0 Td
(in)Tj
1.0375 0 Td
(RNA-seq)Tj
3.9004 0 Td
(data)Tj
1.9162 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(http://immgen.)Tj
-30.5062 -1.2982 Td
(org)Tj
0 g
(\)[)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
4.9265 0 Td
(Analysis)Tj
3.5717 0 Td
(of)Tj
1.0091 0 Td
(human)Tj
3.0671 0 Td
(melanoma)Tj
4.4447 0 Td
(single)Tj
2.5228 0 Td
(cell)Tj
1.5534 0 Td
(RNA-seq)Tj
3.9004 0 Td
(data)Tj
1.9049 0 Td
(from)Tj
2.1996 0 Td
(Tirosh)Tj
2.8573 0 Td
(et)Tj
0.9355 0 Td
(al.)Tj
1.1168 0 Td
(confirms)Tj
-34.0098 -1.304 Td
(that,)Tj
2.0012 0 Td
(in)Tj
1.0375 0 Td
(human)Tj
3.0784 0 Td
(tumors,)Tj
3.3278 0 Td
(CD4)Tj
2.0977 0 Td
(is)Tj
0.8447 0 Td
(co-expressed)Tj
5.3744 0 Td
(with)Tj
2.0013 0 Td
(both)Tj
2.0579 0 Td
(T)Tj
0.8334 0 Td
(cell)Tj
1.559 0 Td
(\(CD3E\))Tj
3.3449 0 Td
(and)Tj
1.7291 0 Td
(myeloid)Tj
3.4639 0 Td
(\(CSF1R\))Tj
-32.7512 -1.2982 Td
(markers)Tj
3.4979 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(]\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
3.4469 0 Td
(1A)Tj
0 g
(\).)Tj
-5.7486 -1.2983 Td
(In)Tj
1.1111 0 Td
(principle,)Tj
4.0252 0 Td
(if)Tj
0.7767 0 Td
(members)Tj
3.9458 0 Td
(of)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(immune)Tj
3.6283 0 Td
(marker)Tj
3.1351 0 Td
(set)Tj
1.3039 0 Td
(are)Tj
1.4457 0 Td
(cell-type)Tj
3.6056 0 Td
(specific,)Tj
3.4186 0 Td
(their)Tj
2.109 0 Td
(transcript)Tj
4.1102 0 Td
(lev-)Tj
-36.0281 -1.2983 Td
(els)Tj
1.2472 0 Td
(should)Tj
2.9197 0 Td
(be)Tj
1.1508 0 Td
(correlated)Tj
4.2463 0 Td
(with)Tj
1.9956 0 Td
(each)Tj
2.0296 0 Td
(other)Tj
2.347 0 Td
(when)Tj
2.4038 0 Td
(examining)Tj
4.4617 0 Td
(a)Tj
0.652 0 Td
(panel)Tj
2.3924 0 Td
(of)Tj
1.0148 0 Td
(tumors.)Tj
3.3278 0 Td
(We)Tj
1.6101 0 Td
(evaluated)Tj
-31.7988 -1.3039 Td
(RNA)Tj
2.262 0 Td
(expression)Tj
4.4617 0 Td
(correlation)Tj
4.6204 0 Td
(across)Tj
2.6759 0 Td
(TCGA)Tj
2.897 0 Td
(solid-tumor)Tj
5.0003 0 Td
(cohorts)Tj
3.2145 0 Td
(for)Tj
1.3889 0 Td
(various)Tj
3.1408 0 Td
(immune)Tj
3.6283 0 Td
(cell)Tj
-33.2898 -1.2982 Td
(marker)Tj
3.135 0 Td
(sets)Tj
1.6611 0 Td
(obtained)Tj
3.7361 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4684 0 Td
(literature)Tj
3.8834 0 Td
(and)Tj
1.7291 0 Td
(from)Tj
2.2054 0 Td
(RNA-seq)Tj
3.9061 0 Td
(of)Tj
1.0148 0 Td
(sorted)Tj
2.7099 0 Td
(immune)Tj
3.6226 0 Td
(cells[)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(].)Tj
3.7758 0 Td
(Our)Tj
-35.053 -1.2983 Td
(analysis)Tj
3.3278 0 Td
(often)Tj
2.2847 0 Td
(revealed)Tj
3.5206 0 Td
(very)Tj
1.9276 0 Td
(low)Tj
1.6554 0 Td
(correlation)Tj
4.6204 0 Td
(for)Tj
1.3833 0 Td
(expression)Tj
4.4674 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(genes)Tj
2.4435 0 Td
(within)Tj
2.8119 0 Td
(each)Tj
2.0296 0 Td
(given)Tj
-32.9553 -1.3039 Td
(immune)Tj
3.6226 0 Td
(marker)Tj
3.1408 0 Td
(set,)Tj
1.525 0 Td
(indicating)Tj
4.269 0 Td
(that)Tj
1.7801 0 Td
(transcripts)Tj
4.4674 0 Td
(with)Tj
2.0012 0 Td
(coordinated)Tj
5.0513 0 Td
(expression)Tj
4.4674 0 Td
(in)Tj
1.0375 0 Td
(sorted)Tj
2.7099 0 Td
(immune)Tj
-34.0722 -1.2983 Td
(cells)Tj
1.9218 0 Td
(are)Tj
1.4457 0 Td
(often)Tj
2.2847 0 Td
(heterogeneously)Tj
6.7294 0 Td
(expressed)Tj
4.0932 0 Td
(in)Tj
1.0375 0 Td
(more)Tj
2.3414 0 Td
(complex)Tj
3.6226 0 Td
(tissue)Tj
2.4548 0 Td
(samples.)Tj
3.6113 0 Td
(For)Tj
1.6271 0 Td
(example,)Tj
3.7757 0 Td
(a)Tj
0.652 0 Td
(reg-)Tj
-35.5972 -1.2982 Td
(ulatory)Tj
3.0557 0 Td
(T)Tj
0.8277 0 Td
(cell)Tj
1.5534 0 Td
(\(Treg\))Tj
2.7666 0 Td
(signature)Tj
3.9117 0 Td
(utilized)Tj
3.1862 0 Td
(in)Tj
1.0318 0 Td
(Rooney)Tj
3.2825 0 Td
(et)Tj
0.9354 0 Td
(al.)Tj
1.1225 0 Td
(was)Tj
1.6951 0 Td
(composed)Tj
4.303 0 Td
(of)Tj
1.0091 0 Td
(seven)Tj
2.4265 0 Td
(genes,)Tj
2.6645 0 Td
(including)Tj
-33.7717 -1.304 Td
(the)Tj
1.4683 0 Td
(FOXP3)Tj
3.1804 0 Td
(transcription)Tj
5.4369 0 Td
(factor,)Tj
2.7666 0 Td
(whose)Tj
2.7212 0 Td
(expression)Tj
4.4674 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.6576 0 Td
(hallmark)Tj
3.7928 0 Td
(of)Tj
1.0148 0 Td
(CD4+)Tj
2.6758 0 Td
(regulatory)Tj
4.32 0 Td
(T)Tj
0.8334 0 Td
(\(Treg\))Tj
-34.1799 -1.2982 Td
(cells[)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(].)Tj
4.9549 0 Td
(Pearson)Tj
3.4242 0 Td
(correlation)Tj
4.6148 0 Td
(analysis)Tj
3.3278 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(other)Tj
2.347 0 Td
(members)Tj
3.9458 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6725 0 Td
(signature)Tj
3.9174 0 Td
(with)Tj
2.0013 0 Td
(FOXP3)Tj
-33.7037 -1.2983 Td
(across)Tj
2.6758 0 Td
(TCGA)Tj
2.897 0 Td
(tumors)Tj
3.1011 0 Td
(revealed)Tj
3.5263 0 Td
(only)Tj
1.9786 0 Td
(1)Tj
0.6916 0 Td
(marker)Tj
3.1351 0 Td
(with)Tj
2.0013 0 Td
(correlation)Tj
4.6147 0 Td
(above)Tj
2.5455 0 Td
(0.5)Tj
1.4003 0 Td
(\(CTLA4,)Tj
3.7587 0 Td
(0.76\))Tj
2.2111 0 Td
(and)Tj
-34.5371 -1.2983 Td
(two)Tj
1.7064 0 Td
(markers)Tj
3.4979 0 Td
(with)Tj
1.9956 0 Td
(correlation)Tj
4.6204 0 Td
(below)Tj
2.5852 0 Td
(0.1)Tj
1.4003 0 Td
(\(IL4,)Tj
2.1373 0 Td
(0.05;)Tj
2.0977 0 Td
(IL5,)Tj
1.8028 0 Td
(0.01\).)Tj
-20.6474 -1.3039 Td
(We)Tj
1.61 0 Td
(therefore)Tj
3.8551 0 Td
(created)Tj
3.1238 0 Td
(alternative)Tj
4.4163 0 Td
(sets)Tj
1.6668 0 Td
(of)Tj
1.0148 0 Td
(transcriptional)Tj
6.1115 0 Td
(markers)Tj
3.4979 0 Td
(for)Tj
1.3889 0 Td
(immune)Tj
3.6227 0 Td
(cell)Tj
1.559 0 Td
(types,)Tj
-33.063 -1.2982 Td
(designed)Tj
3.7643 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1508 0 Td
(appropriate)Tj
4.8756 0 Td
(to)Tj
1.0261 0 Td
(study)Tj
2.3868 0 Td
(of)Tj
1.0148 0 Td
(complex)Tj
3.6226 0 Td
(tumor)Tj
2.744 0 Td
(samples.)Tj
3.6113 0 Td
(We)Tj
1.61 0 Td
(did)Tj
1.5421 0 Td
(this)Tj
1.6724 0 Td
(by)Tj
1.1792 0 Td
(demanding)Tj
4.7849 0 Td
(that)Tj
-36.0111 -1.2983 Td
(members)Tj
3.9458 0 Td
(of)Tj
1.0147 0 Td
(a)Tj
0.652 0 Td
(set)Tj
1.3039 0 Td
(retain)Tj
2.5625 0 Td
(correlation)Tj
4.6148 0 Td
(with)Tj
2.0013 0 Td
(each)Tj
2.0296 0 Td
(other)Tj
2.347 0 Td
(when)Tj
2.4038 0 Td
(examining)Tj
4.456 0 Td
(TCGA)Tj
2.897 0 Td
(tumors,)Tj
3.3279 0 Td
(and)Tj
1.7291 0 Td
(also)Tj
-35.2854 -1.3039 Td
(that)Tj
1.7744 0 Td
(they)Tj
1.9276 0 Td
(are)Tj
1.4456 0 Td
(highly)Tj
2.7099 0 Td
(ranking)Tj
3.3506 0 Td
(neighbors)Tj
4.2009 0 Td
(of)Tj
1.0148 0 Td
(each)Tj
2.0296 0 Td
(other)Tj
2.347 0 Td
(when)Tj
2.4038 0 Td
(looking)Tj
3.2598 0 Td
(at)Tj
0.9468 0 Td
(correlations)Tj
4.9833 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1452 0 Td
(tran-)Tj
-34.5541 -1.2983 Td
(scripts)Tj
2.8176 0 Td
(in)Tj
1.0374 0 Td
(TCGA)Tj
2.8914 0 Td
(RNA-seq)Tj
3.9061 0 Td
(data.)Tj
2.1373 0 Td
(These)Tj
2.5682 0 Td
(sets)Tj
1.6611 0 Td
(were)Tj
2.1259 0 Td
(derived)Tj
3.2145 0 Td
(by)Tj
1.1792 0 Td
(first)Tj
1.8085 0 Td
(evaluating)Tj
4.32 0 Td
(co-expression)Tj
5.7429 0 Td
(of)Tj
-35.4101 -1.2983 Td
(candidate)Tj
4.1045 0 Td
(sentinel)Tj
3.3335 0 Td
(markers)Tj
3.4979 0 Td
(that)Tj
1.7802 0 Td
(displayed)Tj
3.9798 0 Td
(selectivity)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(RNA)Tj
2.262 0 Td
(expression)Tj
4.4617 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(target)Tj
2.5115 0 Td
(cell)Tj
1.559 0 Td
(type)Tj
-35.5008 -1.3039 Td
(\(CD8A)Tj
3.118 0 Td
(for)Tj
1.389 0 Td
(CD8+)Tj
2.6702 0 Td
(T)Tj
0.8334 0 Td
(cells,)Tj
2.143 0 Td
(FOXP3)Tj
3.1861 0 Td
(for)Tj
1.3833 0 Td
(regulatory)Tj
4.32 0 Td
(T)Tj
0.8334 0 Td
(cells,)Tj
2.1429 0 Td
(etc\))Tj
1.7065 0 Td
(with)Tj
1.9956 0 Td
(all)Tj
1.1508 0 Td
(transcripts)Tj
4.4674 0 Td
(across)Tj
2.6816 0 Td
(TCGA)Tj
-34.0212 -1.2982 Td
(solid-tumor)Tj
5.0002 0 Td
(cohorts)Tj
3.2202 0 Td
(\(details)Tj
3.1181 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0318 0 Td
(Methods)Tj
0 g
(\).)Tj
4.3256 0 Td
(We)Tj
1.6101 0 Td
(then)Tj
2.0182 0 Td
(used)Tj
2.058 0 Td
(a)Tj
0.6519 0 Td
(stringent)Tj
3.8041 0 Td
(metric)Tj
2.8233 0 Td
(of)Tj
1.0148 0 Td
(mutual)Tj
3.0727 0 Td
(rank)Tj
2.0693 0 Td
(dis-)Tj
-35.8183 -1.2983 Td
(tance)Tj
2.347 0 Td
(to)Tj
1.0262 0 Td
(identify)Tj
3.2938 0 Td
(gene)Tj
2.0806 0 Td
(neighbors)Tj
4.2009 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4684 0 Td
(sentinel)Tj
3.3392 0 Td
(markers[)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(])Tj
5.125 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Table)Tj
2.7836 0 Td
(1)Tj
0 g
(\).)Tj
1.2642 0 Td
(The)Tj
1.7802 0 Td
(principle)Tj
3.804 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
-34.9112 -1.3039 Td
(mutual)Tj
3.0727 0 Td
(rank)Tj
2.0693 0 Td
(metric)Tj
2.8233 0 Td
(is)Tj
0.8503 0 Td
(that)Tj
1.7745 0 Td
(that)Tj
1.7802 0 Td
(highest)Tj
3.0897 0 Td
(scoring)Tj
3.1635 0 Td
(gene)Tj
2.0806 0 Td
(neighbors)Tj
4.2009 0 Td
(are)Tj
1.4457 0 Td
(not)Tj
1.576 0 Td
(only)Tj
1.9786 0 Td
(highly)Tj
2.7042 0 Td
(correlated)Tj
-32.6095 -1.2983 Td
(with)Tj
1.9955 0 Td
(each)Tj
2.0296 0 Td
(other,)Tj
2.5739 0 Td
(but)Tj
1.5533 0 Td
(are)Tj
1.4457 0 Td
(also)Tj
1.7688 0 Td
(each)Tj
2.0296 0 Td
(other's)Tj
2.9253 0 Td
(highest)Tj
3.0898 0 Td
(ranking)Tj
3.3505 0 Td
(match,)Tj
2.948 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
0.6577 0 Td
(penalty)Tj
3.1407 0 Td
(is)Tj
0.8504 0 Td
(applied)Tj
3.1521 0 Td
(as)Tj
-35.24 -1.2982 Td
(these)Tj
2.2506 0 Td
(mutual)Tj
3.0785 0 Td
(ranks)Tj
2.4264 0 Td
(become)Tj
3.3278 0 Td
(lower.)Tj
2.6759 0 Td
(These)Tj
2.5682 0 Td
(methods)Tj
3.685 0 Td
(were)Tj
2.1203 0 Td
(employed)Tj
4.1386 0 Td
(to)Tj
1.0261 0 Td
(limit)Tj
2.1203 0 Td
(the)Tj
1.4684 0 Td
(inclusion)Tj
3.9174 0 Td
(of)Tj
-34.8035 -1.2983 Td
(transcripts)Tj
4.473 0 Td
(that)Tj
1.7745 0 Td
(are)Tj
1.4513 0 Td
(present)Tj
3.1634 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.652 0 Td
(more)Tj
2.3414 0 Td
(diverse)Tj
3.05 0 Td
(range)Tj
2.4605 0 Td
(of)Tj
1.0148 0 Td
(cell)Tj
1.559 0 Td
(types)Tj
2.2734 0 Td
(than)Tj
2.0296 0 Td
(the)Tj
1.4683 0 Td
(sentinel)Tj
3.3392 0 Td
(\(manuscript)Tj
-32.0879 -1.3039 Td
(in)Tj
1.0318 0 Td
(preparation\).)Tj
0.83 0.64 0.02 0 k
0.1644 -1.2983 Td
(Fig)Tj
1.4853 0 Td
(1B)Tj
0 g
1.2699 0 Td
(presents)Tj
3.5263 0 Td
(one)Tj
1.7008 0 Td
(example,)Tj
3.7757 0 Td
(a)Tj
0.652 0 Td
(view)Tj
2.0522 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(\(mutual)Tj
3.4129 0 Td
(rank\))Tj
2.4094 0 Td
(co-regulatory)Tj
5.6012 0 Td
(network)Tj
3.549 0 Td
(around)Tj
-33.1141 -1.2983 Td
(FOXP3,)Tj
3.4072 0 Td
(a)Tj
0.6519 0 Td
(canonical)Tj
4.0536 0 Td
(marker)Tj
3.1351 0 Td
(of)Tj
1.0147 0 Td
(immuno-suppressive)Tj
8.6457 0 Td
(regulatory)Tj
4.3199 0 Td
(T)Tj
0.8334 0 Td
(cells.)Tj
2.143 0 Td
(Transcript)Tj
4.422 0 Td
(abundances)Tj
-32.6265 -1.3039 Td
(for)Tj
1.3832 0 Td
(CCR8)Tj
2.6476 0 Td
(possessed)Tj
4.0592 0 Td
(a)Tj
0.6576 0 Td
(both)Tj
2.058 0 Td
(a)Tj
0.6519 0 Td
(strong)Tj
2.7723 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(selective)Tj
3.5433 0 Td
(correlation)Tj
4.6148 0 Td
(to)Tj
1.0261 0 Td
(FOXP3)Tj
3.1805 0 Td
(when)Tj
2.4094 0 Td
(compared)Tj
-32.8533 -1.2982 Td
(to)Tj
1.0261 0 Td
(other)Tj
2.3471 0 Td
(neighbors,)Tj
4.422 0 Td
(including)Tj
4.0422 0 Td
(transcripts)Tj
4.473 0 Td
(probably)Tj
3.7644 0 Td
(more)Tj
2.3414 0 Td
(reflective)Tj
3.8381 0 Td
(of)Tj
1.0148 0 Td
(pan-T)Tj
2.6815 0 Td
(cell)Tj
1.5591 0 Td
(content)Tj
3.2711 0 Td
(\(CD3)Tj
-34.7808 -1.2983 Td
(epsilon/CD3E,)Tj
6.0887 0 Td
(CD2\),)Tj
2.6589 0 Td
(or)Tj
1.0998 0 Td
(markers)Tj
3.498 0 Td
(correlated)Tj
4.2463 0 Td
(with)Tj
1.9955 0 Td
(both)Tj
2.0636 0 Td
(FOXP3)Tj
3.1805 0 Td
(and)Tj
1.7291 0 Td
(pan-T)Tj
2.6816 0 Td
(markers)Tj
3.4979 0 Td
(\(TIGIT,)Tj
-32.7399 -1.3039 Td
(ICOS\).)Tj
3.0103 0 Td
(A)Tj
0.9014 0 Td
(similar)Tj
2.9877 0 Td
(mutual)Tj
3.0728 0 Td
(rank)Tj
2.0749 0 Td
(analysis)Tj
3.3222 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(Tiros)Tj
2.3414 0 Td
(et)Tj
0.9411 0 Td
(al.)Tj
1.1225 0 Td
(single)Tj
2.5342 0 Td
(cell)Tj
1.5591 0 Td
(melanoma)Tj
4.4503 0 Td
(RNA-seq)Tj
3.9061 0 Td
(con-)Tj
-34.7071 -1.2983 Td
(firmed)Tj
2.9139 0 Td
(the)Tj
1.4741 0 Td
(co-expression)Tj
5.7429 0 Td
(of)Tj
1.0148 0 Td
(FOXP3)Tj
3.1805 0 Td
(and)Tj
1.7348 0 Td
(CCR8)Tj
2.6418 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8199 0 Td
(1C)Tj
0 g
(\).)Tj
1.9218 0 Td
(FOXP3)Tj
3.1862 0 Td
(and)Tj
1.7291 0 Td
(CCR8)Tj
2.6419 0 Td
(were)Tj
2.1259 0 Td
(ultimately)Tj
-32.1276 -1.2983 Td
(chosen)Tj
3.0103 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(signature)Tj
3.9174 0 Td
(set)Tj
1.304 0 Td
(for)Tj
1.3833 0 Td
(Treg)Tj
2.0919 0 Td
(estimation.)Tj
4.6715 0 Td
(Signature)Tj
4.0308 0 Td
(sets)Tj
1.6668 0 Td
(for)Tj
1.3833 0 Td
(other)Tj
2.3471 0 Td
(immune)Tj
3.6283 0 Td
(cell)Tj
1.559 0 Td
(types)Tj
2.2734 0 Td
(were)Tj
-34.9339 -1.3039 Td
(derived)Tj
3.2144 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.652 0 Td
(similar)Tj
2.9877 0 Td
(fashion;)Tj
3.3788 0 Td
(for)Tj
1.3833 0 Td
(macrophages,)Tj
5.7316 0 Td
(a)Tj
0.652 0 Td
(highly)Tj
2.7099 0 Td
(co-regulated)Tj
5.2157 0 Td
(set)Tj
1.304 0 Td
(\(VSIG4,)Tj
3.4866 0 Td
(CD163,)Tj
-31.7535 -1.2982 Td
(MS4A4A\))Tj
4.2406 0 Td
(was)Tj
1.6951 0 Td
(derived)Tj
3.2088 0 Td
(\(Macrophage:)Tj
0.83 0.64 0.02 0 k
5.7769 0 Td
(Fig)Tj
1.474 0 Td
(1D)Tj
0 g
(\).)Tj
1.9956 0 Td
(To)Tj
1.3323 0 Td
(create)Tj
2.5852 0 Td
(a)Tj
0.6519 0 Td
(quantitative)Tj
4.972 0 Td
(score)Tj
2.3017 0 Td
(from)Tj
2.1997 0 Td
(the)Tj
1.4626 0 Td
(signature)Tj
-33.8964 -1.2983 Td
(genes,)Tj
2.6645 0 Td
(simple)Tj
2.8573 0 Td
(medians)Tj
3.6 0 Td
(of)Tj
1.0148 0 Td
(each)Tj
2.0296 0 Td
(marker)Tj
3.1351 0 Td
(set)Tj
1.3039 0 Td
(were)Tj
2.1203 0 Td
(used,)Tj
2.2847 0 Td
(once)Tj
2.126 0 Td
(individual)Tj
4.2859 0 Td
(marker)Tj
3.1351 0 Td
(expression)Tj
4.4674 0 Td
(was)Tj
-35.0246 -1.2983 Td
(normalized)Tj
4.7791 0 Td
(to)Tj
1.0205 0 Td
(a)Tj
0.6576 0 Td
(standard)Tj
3.7191 0 Td
(distribution)Tj
4.9719 0 Td
(\(details)Tj
3.1181 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0318 0 Td
(Methods)Tj
0 g
(\).)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 371.9622 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Identifying)Tj
4.6913 0 Td
(genetic)Tj
3.3804 0 Td
(correlates)Tj
4.5354 0 Td
(of)Tj
1.0418 0 Td
(immune)Tj
3.7205 0 Td
(infiltrate)Tj
3.4228 0 Td
(s)Tj
0.7158 0 Td
(in)Tj
0.978 0 Td
(tumors)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01797)Tj
4.089 0 Td
(26)Tj
0 g
2.0906 0 Td
(July)Tj
1.9701 0 Td
(27,)Tj
1.5874 0 Td
(2017)Tj
35.3483 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
76 0 obj
<>stream
endstream
endobj
77 0 obj
<>stream
endstream
endobj
78 0 obj
<>stream
endstream
endobj
79 0 obj
<>stream
endstream
endobj
80 0 obj
<>stream
endstream
endobj
81 0 obj
<>stream
endstream
endobj
82 0 obj
<>stream
endstream
endobj
83 0 obj
<>stream
endstream
endobj
84 0 obj
<>stream
endstream
endobj
85 0 obj
<>stream
endstream
endobj
86 0 obj
<>stream
BT
66.402 0 Td
(24)Tj
ET
Q
endstream
endobj
87 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 90 0 R/Contents 91 0 R/TrimBox[0 0 612 792]>>
endobj
89 0 obj
<>stream
xwUŹ3ͨD{]"cEElF`-ĆX"W#.Y>3k9sY<^ffg'" " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " "0|7ݪRD@D@D@D@D@D@D@D@D@D@~eo?O _?vFD<~eoK/+ܹsnݺm}4h/)S̙3?A8E4+_zX"D@D@D@D@D@D@D@D@D@D@DI}7ϿkHg̘UK[놲WD@D@D@D@D@D@D@D@D \x
-xMN'" " " " " " " " " " -C??K{ҵk?ZJE`M6iȏ}?ѱة" " " " " " " " " " "?4oϞ=[YD@D@D@D@D@D@D@D@D@D2^xa?XhNZe6Jk;wΝFoyKSOojۼFQ" " " " " " " " " " "ڽf;yгgϛoFhufEu{駟u&_D@D@D@D@D@D@D@D@D@D@J m^"f^)>J," " " " " " " " " ?שӶ<." " " " " " " " " " tvR`uֹ{;VE@D@D@D@D@D@D@D@D@DCÊ9%"" " " " " " " " " " m@Gl6a+-" " " " " " " " " ":u]~+W^}Q4A@3耚m?ofAD@D@D@D@D@D@D@D@D@ ]tQnO>ٜMU" " " " " " " " " " ":f;yp'KJenB;.Nk
(B#kyME:҈t@_~e]cuCb^{?RUE@D@D@D@D@D@D@D@D@D@:&_1oZ-" " " " " " " " " 9n矿!
B'l/>`{jONZ7*rذaD@D@D@D@D@D@D@D@D@D@DMf&V OkF٩?VhyNf{M6pNK9Oo~sQG
4b[.#wy~/d4 c7|S~ɓ'7I{e@=ocLJ~_~mO>>xwΝ矫?*E?щ9v45DD,O?e,W)[HLбgEi5}2~G}YiZ*" -DfNh!ce
{nʔ)7tg{,B9?;2@" " " " " " " " " "Сxeb~+ j.lwhzѵk5\suYtM:/r
?k֬R%4bW]u%\Bi]w>tk^ n={֭/ˤ?z۷Q{ヲAO<Vq##/a3S⋯^y?K/
4Qכo7c^|EZ?xkT"` m+կ~oN;wftҥ3zN;5'njЁpo7(XWdLgq;%J\[o
7dY˧Z]֒6q#ve[{KAGtm)Rv^u?S裏=kJSӦM]aݠ_~~衇*ܗ0Y~?~ԩ[
/+ ^wuR[*Cf#l>|byy7. W36CdC/+S/KyRU-"P o:+ҏ~aa%@#wq6a矟 )kag:uDh#
Ds&9<0{.bHu~gl_~}A7jtIXō z{SCdelZEY$
+2=li.=[l1[8a&NR%;~P;
Z\U@q+إZj7F~ȣ͎,
/ɳƀYJ*L
ad еX`^x_vedsJդLTN>bbwcB'X2i)G6lRѹHekLl.ҫJѣ:jܸqnCTU,(9K+({״xrO>tr {*x[-[x֒Ǎ>yG˛zMp"{?8lXcAբ:~o.k12lkr6xcƌ9#mfLHtLe-!1aMbJ "P@GQMV~d@ʟJO֢ph~-MknqD$p<I9~jJ_ФV7pC;?sL ۨfE]ӟ'46 >`\;{ZۘbAƐWC48YH,6T.6R4$1
)V@Лo"+P'|U